Browse > Article
http://dx.doi.org/10.4062/biomolther.2012.096

DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia  

Kwon, Yong Sam (Dong-A ST Research Institute)
Son, Miwon (Dong-A ST Research Institute)
Publication Information
Biomolecules & Therapeutics / v.21, no.3, 2013 , pp. 181-189 More about this Journal
Abstract
Motilitone$^{(R)}$ (DA-9701) is a new herbal drug that was launched for the treatment of functional dyspepsia in December 2011 in Korea. The heterogeneous symptom pattern and multiple causes of functional dyspepsia have resulted in multiple drug target strategies for its treatment. DA-9701, a compound consisting of a combination of Corydalis Tuber and Pharbitidis Semen, has being developed for treatment of functional dyspepsia. It has multiple mechanisms of action such as fundus relaxation, visceral analgesia, and prokinetic effects. Furthermore, it was found to significantly enhance meal-induced gastric accommodation and increase gastric compliance in dogs. DA-9701 also showed an analgesic effect in rats with colorectal distension induced visceral hypersensitivity and an antinociceptive effect in beagle dogs with gastric distension-induced nociception. The pharmacological effects of DA-9701 also include conventional effects, such as enhanced gastric emptying and gastrointestinal transit. The safety profile of DA-9701 is also preferable to that of other treatments.
Keywords
DA-9701; Functional dyspepsia; Pharmacology; Gastric accommodation; Visceral hypersensitivity; Prokinetics;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Kumar, S., Kumar, D., Singh, J., Narender, R. and Kaushik, D. (2009) Anti-infl ammatory, Analgesic and Antioxidant Activities of Ipomoea hederaceae Linn. Planta Med. 75, P-100.
2 Lee, T. H., Choi, J. J., Kim, D. H., Choi, S., Lee, K. R., Son, M. and Jin, M. (2008) Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber. Phytomedicine 15, 836-843.   DOI   ScienceOn
3 Lee, T. H., Kim, K. H., Lee, S. O., Lee, K. R., Son, M. and Jin, M. (2011) Tetrahydroberberine, an isoquinoline alkaloid isolated from corydalis tuber, enhances gastrointestinal motor function. J. Pharmacol. Exp. Ther. 338, 917-924.   DOI   ScienceOn
4 Lei, Y., Zhu, H., Xing, J. and Chen, J. D. (2005) Rectal distension modulates canine gastric tone and accommodation. Dig. Dis. Sci. 50, 2134-2140.   DOI
5 Lidow, M. S. (2002) Long-term effects of neonatal pain on nociceptive systems. Pain 99, 377-383.   DOI   ScienceOn
6 Lim, H. C., Park, H., Lee, S. I., Jahng, J. and Lee, Y. J. (2012) Tu1985 effects of DA-9701, a novel prokinetic agent on gastric motor function in guinea pig. Gastroenterology 142, S893-S894.
7 Lin, C. and Al-Chaer, E. D. (2003) Long-term sensitization of primary afferents in adult rats exposed to neonatal colon pain. Brain Res. 971, 73-82.   DOI   ScienceOn
8 Ma, Z. Z., Xu, W., Jensen, N. H., Roth, B. L., Liu-Chen, L. Y. and Lee, D. Y. (2008) Isoquinoline alkaloids isolated from Corydalis yanhusuo and their binding affi nities at the dopamine D1 receptor. Molecules 13, 2303-2312.   DOI
9 Mackie, A. D., Ferrington, C., Cowan, S., Merrick, M. V., Baird, J. D. and Palmer, K. R. (1991) The effects of renzapride, a novel prokinetic agent, in diabetic gastroparesis. Aliment. Pharmacol. Ther. 5, 135-142.
10 Madsen, J. L. and Fuglsang, S. (2008) A randomized, placebo-controlled, crossover, double-blind trial of the NK1 receptor antagonist aprepitant on gastrointestinal motor function in healthy humans. Aliment. Pharmacol. Ther. 27, 609-615.   DOI   ScienceOn
11 Graca, J. R., Leal, P. R., Gondim, F. A., Rola, F. H. and Santos, A. A. (2002) Variations in gastric compliance induced by acute blood volume changes in anesthetized rats. Braz. J. Med. Biol. Res. 35, 405-410.   DOI
12 Halder, S. L. and Talley, N. J. (2007) Functional Dyspepsia: A New Rome III Paradigm. Curr. Treat. Options Gastroenterol. 10, 259-272.   DOI   ScienceOn
13 Hallerback, B. I., Bommelaer, G., Bredberg, E., Campbell, M., Hellblom, M., Lauritsen, K., Wienbeck, M. and Holmgren, L. L. (2002) Dose fi nding study of mosapride in functional dyspepsia: a placebo-controlled, randomized study. Aliment. Pharmacol. Ther. 16, 959-967.   DOI   ScienceOn
14 Hancock, B. D., Bowen-Jones, E., Dixon, R., Dymock, I. W. and Cowley, D. J. (1974) The effect of metoclopramide on gastric emptying of solid meals. Gut 15, 462-467.   DOI   ScienceOn
15 Harada, Y., Nishioka, K., Kitahata, L. M., Kishikawa, K. and Collins, J. G. (1995) Visceral antinociceptive effects of spinal clonidine combined with morphine, [D-Pen2, D-Pen5] enkephalin, or U50,488H. Anesthesiology 83, 344-352.   DOI   ScienceOn
16 Herman, M. A., Niedringhaus, M., Alayan, A., Verbalis, J. G., Sahibzada, N. and Gillis, R. A. (2008) Characterization of noradrenergic transmission at the dorsal motor nucleus of the vagus involved in refl ex control of fundus tone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294, R720-729.   DOI   ScienceOn
17 Hirokawa, Y., Yamazaki, H., Yoshida, N. and Kato, S. (1998) A novel series of 6-methoxy-1H-benzotriazole-5-carboxamide derivatives with dual antiemetic and gastroprokinetic activities. Bioorg. Med. Chem. Lett. 8, 1973-1978.   DOI   ScienceOn
18 Janssen, P., Tack, J., Sifrim, D., Meulemans, A. L. and Lefebvre, R. A. (2004) Infl uence of 5-HT1 receptor agonists on feline stomach relaxation. Eur. J. Pharmacol. 492, 259-267.   DOI   ScienceOn
19 Houghton, L. A., Cremonini, F., Camilleri, M., Busciglio, I., Fell, C., Cox, V., Alpers, D. H., Dewit, O. E., Dukes, G. E., Gray, E., Lea, R., Zinsmeister, A. R. and Whorwell, P. J. (2007) Effect of the NK(3) receptor antagonist, talnetant, on rectal sensory function and compliance in healthy humans. Neurogastroenterol. Motil. 19, 732-743.   DOI   ScienceOn
20 Jahnberg, T., Martinson, J., Hulten, L. and Fasth, S. (1975) Dynamic gastric response to expansion before and after vagotomy. Scand. J. Gastroenterol. 10, 593-598.
21 Jia, W., Wang, X., Xu, D., Zhao, A. and Zhang, Y. (2006) Common traditional Chinese medicinal herbs for dysmenorrhea. Phytother. Res. 20, 819-824.   DOI   ScienceOn
22 Jung, Y. S., Kim, M. Y., Lee, H. S., Park, S. L. and Lee, K. J. (2013) Effect of DA-9701, a novel prokinetic agent, on stress-induced delayed gastric emptying and hormonal changes in rats. Neurogastroenterol. Motil. 25, 254-259.   DOI   ScienceOn
23 Kamigauchi, M. and Iwasa, K. (1994) Corydalis spp.: in vitro culture and the biotransformation of protoberberines. Biotechnol. Agric. For. 26, 93-105.
24 Kanaizumi, T., Nakano, H., Matsui, Y., Ishikawa, H., Shimizu, R., Park, S. and Kuriya, N. (1991) Prokinetic effect of AS-4370 on gastric emptying in healthy adults. Eur. J. Clin. Pharmacol. 41, 335-337.   DOI   ScienceOn
25 De Ponti, F., Crema, F., Moro, E., Nardelli, G., Frigo, G. and Crema, A. (2003) Role of 5-HT1B/D receptors in canine gastric accommodation: effect of sumatriptan and 5-HT1B/D receptor antagonists. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G96-104.
26 Ding, B., Zhou, T., Fan, G., Hong, Z. and Wu, Y. (2007) Qualitative and quantitative determination of ten alkaloids in traditional Chinese medicine Corydalis yanhusuo W.T. Wang by LC-MS/MS and LCDAD. J. Pharm. Biomed. Anal. 45, 219-226.   DOI   ScienceOn
27 Degen, L., Matzinger, D., Merz, M., Appel-Dingemanse, S., Osborne, S., Luchinger, S., Bertold, R., Maecke, H. and Beglinger, C. (2001) Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment. Pharmacol. Ther. 15, 1745-1751.   DOI   ScienceOn
28 Degryse, H., De Schepper, A. and Verlinden, M. (1993) A double-blind fl uoroscopic study of cisapride on gastrointestinal motility in patients with functional dyspepsia. Scand. J. Gastroenterol. Suppl. 195, 1-4.
29 Delvaux, M., Louvel, D., Mamet, J. P., Campos-Oriola, R. and Frexinos, J. (1998) Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 12, 849-855.   DOI   ScienceOn
30 Drossman, D. A. (1999) The functional gastrointestinal disorders and the Rome II process. Gut 45 Suppl. 2, II1-5.   DOI
31 Dukes, G. E., Talley, N. J., van Zanten, S. V., Heath, M., Sorrells, S. C., Perschy, T. B., Kleoudis, C. and Mangel, A. W. (2000) A doseranging, placebo-controlled, randomized clinical trial of alosetron, a 5-HT3 receptor antagonist, in the treatment of functional (nonulcer) dyspepsia. Am. J. Gastroenterol. 95, 2451.
32 Dumitrascu, D. L., Ungureanu, O., Verzea, D. and Pascu, O. (1998) The effect of metoclopramide on antral emptying of a semisolid meal in patients with functional dyspepsia. A randomized placebo controlled sonographic study. Rom. J. Intern. Med. 36, 97-104.
33 Dumuis, A., Sebben, M. and Bockaert, J. (1989) The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn Schmiedebergs Arch. Pharmacol. 340, 403-410.   DOI
34 Blackshaw, L. A., Grundy, D. and Scratcherd, T. (1987) Vagal afferent discharge from gastric mechanoreceptors during contraction and relaxation of the ferret corpus. J. Auton. Nerv. Syst. 18, 19-24.   DOI   ScienceOn
35 Ejskjaer, N., Vestergaard, E. T., Hellstrom, P. M., Gormsen, L. C., Madsbad, S., Madsen, J. L., Jensen, T. A., Pezzullo, J. C., Christiansen, J. S., Shaughnessy, L. and Kosutic, G. (2009) Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.Aliment. Pharmacol. Ther. 29, 1179-1187.   DOI   ScienceOn
36 Galligan, J. J. and Burks, T. F. (1983) Centrally mediated inhibition of small intestinal transit and motility by morphine in the rat. J. Pharmacol. Exp. Ther. 226, 356-361.
37 Gilja, O. H., Hausken, T., Bang, C. J. and Berstad, A. (1997) Effect of glyceryl trinitrate on gastric accommodation and symptoms in functional dyspepsia. Dig. Dis. Sci. 42, 2124-2131.   DOI   ScienceOn
38 Boeckxstaens, G. E., Tytgat, G. N., Wajs, E., Van Nueten, L., De Ridder, F., Meulemans, A. and Tack, J. (2006) The infl uence of the novel 5-HT1A agonist R137696 on the proximal stomach function in healthy volunteers. Neurogastroenterol. Motil. 18, 919-926.   DOI   ScienceOn
39 Bradesi, S., Herman, J. and Mayer, E. A. (2008) Visceral analgesics: drugs with a great potential in functional disorders? Curr. Opin. Pharmacol. 8, 697-703.   DOI   ScienceOn
40 Brun, R. and Kuo, B. (2010) Functional dyspepsia. Therap. Adv. Gastroenterol. 3, 145-164.   DOI   ScienceOn
41 Camilleri, M., Bueno, L., de Ponti, F., Fioramonti, J., Lydiard, R. B. and Tack, J. (2006) Pharmacological and pharmacokinetic aspects of functional gastrointestinal disorders. Gastroenterology 130, 1421-1434.   DOI   ScienceOn
42 Cannon, W. B. and Lieb, C. W. (1911) The receptive relaxation of the stomach. Am. J. Physiol. 29, 267-273.
43 Chung, E. K., Zhang, X., Li, Z., Zhang, H., Xu, H. and Bian, Z. (2007a) Neonatal maternal separation enhances central sensitivity to noxious colorectal distention in rat. Brain. Res. 1153, 68-77.   DOI   ScienceOn
44 Cao, F. L., Shang, G. W., Wang, Y., Yang, F., Li, C. L. and Chen, J. (2011) Antinociceptive effects of intragastric dl-tetrahydropalmatine on visceral and somatic persistent nociception and pain hypersensitivity in rats. Pharmacol. Biochem. Behav. 100, 199-204.   DOI   ScienceOn
45 Choi, S., Choi, J. J., Jun, J. Y., Koh, J. W., Kim, S. H., Kim, D. H., Pyo, M. Y., Son, J. P., Lee, I., Son, M. and Jin, M. (2009) Induction of pacemaker currents by DA-9701, a prokinetic agent, in interstitial cells of Cajal from murine small intestine. Mol. Cells 27, 307-312.   DOI   ScienceOn
46 Choung, R. S., Talley, N. J., Peterson, J., Camilleri, M., Burton, D., Harmsen, W. S. and Zinsmeister, A. R. (2007) A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Neurogastroenteol. Motil. 19, 180-187.   DOI   ScienceOn
47 Chung, E. K., Zhang, X. J., Xu, H. X., Sung, J. J. and Bian, Z. X. (2007b) Visceral hyperalgesia induced by neonatal maternal separation is associated with nerve growth factor-mediated central neuronal plasticity in rat spinal cord. Neuroscience 149, 685-695.   DOI   ScienceOn
48 Coffi n, B., Bouhassira, D., Chollet, R., Fraitag, B., De Meynard, C., Geneve, J., Lemann, M., Willer, J. C. and Jian, R. (1996) Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans. Aliment. Pharmacol. Ther. 10, 919-925.   DOI
49 Coulie, B., Tack, J., Sifrim, D., Andrioli, A. and Janssens, J. (1999). Role of nitric oxide in fasting gastric fundus tone and in 5-HT1 receptor-mediated relaxation of gastric fundus. Am. J. Physiol. 276, G373-377.
50 Danzebrink, R. M. and Gebhart, G. F. (1990) Antinociceptive effects of intrathecal adrenoceptor agonists in a rat model of visceral nociception. J. Pharmacol. Exp. Ther. 253, 698-705.
51 Adsersen, A., Kjolbye, A., Dall, O. and Jager, A. K. (2007) Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort. J. Ethnopharmacol. 113, 179-182.   DOI   ScienceOn
52 Agreus, L., Svardsudd, K., Nyren, O. and Tibblin, G. (1995) Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109, 671-680.   DOI   ScienceOn
53 Al-Chaer, E. D., Kawasaki, M. and Pasricha, P. J. (2000) A new model of chronic visceral hypersensitivity in adult rats induced by colon irritation during postnatal development. Gastroenterology 119, 1276-1285.   DOI   ScienceOn
54 Azpiroz, F. and Malagelada, J. R. (1985) Physiological variations in canine gastric tone measured by an electronic barostat. Am. J. Physiol. 248, G229-237.
55 Azpiroz, F. and Malagelada, J. R. (1986) Vagally mediated gastric relaxation induced by intestinal nutrients in the dog. Am. J. Physiol. 251, G727-735.
56 Banani, S. J., Lankarani, K. B., Taghavi, A., Bagheri, M. H., Sefi dbakht, S. and Geramizadeh, B. (2008) Comparison of metoclopramide oral tablets and solution in treatment of dysmotility-like dyspepsia. Am. J. Health Syst. Pharm. 65, 1057-1061.   DOI   ScienceOn
57 Bisschops, R. and Tack, J. (2007) Dysaccommodation of the stomach: therapeutic nirvana? Neurogastroenterol. Motil. 19, 85-93.   DOI   ScienceOn
58 Talley, N. J., Tack, J., Ptak, T., Gupta, R. and Giguere, M. (2008) Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 57, 740-746.   DOI   ScienceOn
59 Zhao, J., Liao, D. and Gregersen, H. (2005) Tension and stress in the rat and rabbit stomach are location- and direction-dependent. Neurogastroenterol. Motil. 17, 388-398.   DOI   ScienceOn
60 Talley, N. J., Locke, G. R., 3rd, Herrick, L. M., Silvernail, V. M., Prather, C. M., Lacy, B. E., DiBaise, J. K., Howden, C. W., Brenner, D. M., Bouras, E. P., El-Serag, H. B., Abraham, B. P., Moayyedi, P. and Zinsmeister, A. R. (2012) Functional Dyspepsia Treatment Trial (FDTT): a double-blind, randomized, placebo-controlled trial of antidepressants in functional dyspepsia, evaluating symptoms, psychopathology, pathophysiology and pharmacogenetics. Contemp. Clin. Trials 33, 523-533.   DOI   ScienceOn
61 Talley, N. J., Zinsmeister, A. R., Schleck, C. D. and Melton, L. J. 3rd (1992) Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 102, 1259-1268.
62 Tanila, H., Kauppila, T. and Taira, T. (1993) Inhibition of intestinal motility and reversal of postlaparotomy ileus by selective alpha 2-adrenergic drugs in the rat. Gastroenterology 104, 819-824.
63 Taniyama, K., Nakayama, S., Takeda, K., Matsuyama, S., Shirakawa, J., Sano, I. and Tanaka, C. (1991) Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J. Pharmacol. Exp. Ther. 258, 1098-1104.
64 Thumshirn, M., Camilleri, M., Choi, M. G. and Zinsmeister, A. R. (1999) Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 116, 573-585.   DOI   ScienceOn
65 Tomita, T., Okugawa, T., Yamasaki, T., Kondo, T., Toyoshima, F., Sakurai, J., Oshima, T., Fukui, H., Daimon, T., Watari, J., Kashiwagi, T., Matsumoto, T. and Miwa, H. (2013) Use of scintigraphy to evaluate gastric accommodation and emptying: comparison with barostat. J. Gastroenterol. Hepatol. 28, 106-111.   DOI   ScienceOn
66 Wang, S. and Mo, W. Y. (1989) Effect of intraseptal noradrenaline on somatic and visceral pain threshold of rabbits. Sheng Li Xue Bao 41, 128-135.
67 Van Oudenhove, L., Kindt, S., Vos, R., Coulie, B. and Tack, J. (2008) Influence of buspirone on gastric sensorimotor function in man. Aliment. Pharmacol. Ther. 28, 1326-1333.   DOI   ScienceOn
68 Veldhuyzen van Zanten, S. J., Jones, M. J., Verlinden, M. and Talley, N. J. (2001) Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis. Am. J. Gastroenterol 96, 689-696.   DOI   ScienceOn
69 Wang, C., Wang, S., Fan, G. and Zou, H. (2010) Screening of antinociceptive components in Corydalis yanhusuo W.T. Wang by comprehensive two-dimensional liquid chromatography/tandem mass spectrometry. Anal. Bioanal. Chem. 396, 1731-1740.   DOI
70 Williams, P. D., Colbert, W. E., Shetler, T. J. and Turk, J. A. (1992) Comparative pharmacological profi le of muscarinic agonists in the isolated ileum, the pithed rat, and the mouse charcoal meal transit test. Gen. Pharmacol. 23, 177-185.   DOI   ScienceOn
71 Yin, J., Ouyang, H. and Chen, J. D. (2007) Potential of intestinal electrical stimulation for obesity: a preliminary canine study. Obesity (Silver Spring) 15, 1133-1138.   DOI
72 Tack, J. (2009) Mandatory and optional function tests in gastroduodenal disorders. Best Pract. Res. Clin. Gastroenterol. 23, 387-393.   DOI   ScienceOn
73 Tack, J., Broeckaert, D., Coulie, B. and Janssens, J. (1998a) The infl uence of cisapride on gastric tone and the perception of gastric distension. Aliment. Pharmacol. Ther. 12, 761-766.   DOI   ScienceOn
74 Tack, J., Broekaert, D., Coulie, B., Fischler, B. and Janssens, J. (2003a) Infl uence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment. Pharmacol. Ther. 17, 603-608.   DOI   ScienceOn
75 Tack, J. and Janssen, P. (2011b) Emerging drugs for functional dyspepsia. Expert Opin. Emerg. Drugs 16, 283-292.   DOI   ScienceOn
76 Tack, J., Caenepeel, P., Corsetti, M. and Janssens, J. (2004) Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention. Gastroenterology 127, 1058-1066.   DOI   ScienceOn
77 Tack, J., Caenepeel, P., Fischler, B., Piessevaux, H. and Janssens, J. (2001) Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 121, 526-535.   DOI   ScienceOn
78 Tack, J. and Janssen, P. (2011a) Acotiamide (Z-338, YM443), a new drug for the treatment of functional dyspepsia. Expert Opin. Investig. Drugs 20, 701-712.   DOI   ScienceOn
79 Tack, J., Masclee, A., Heading, R., Berstad, A., Piessevaux, H., Popiela, T., Vandenberghe, A. and Kato, H. (2009a) A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia. Neurogastroenterol. Motil. 21, 272-280.   DOI   ScienceOn
80 Tack, J., Piessevaux, H., Coulie, B., Caenepeel, P. and Janssens, J. (1998b) Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 115, 1346-1352.   DOI   ScienceOn
81 Tack, J., Talley, N. J., Camilleri, M., Holtmann, G., Hu, P., Malagelada, J. R. and Stanghellini, V. (2006) Functional gastroduodenal disorders. Gastroenterology 130, 1466-1479.   DOI   ScienceOn
82 Tack, J., Van Den Elzen, B., Tytgat, G., Wajs, E., Van Nueten, L., De Ridder, F. and Boeckxstaens, G. (2009b) A placebo-controlled trial of the 5-HT1A agonist R-137696 on symptoms, visceral hypersensitivity and on impaired accommodation in functional dyspepsia. Neurogastroenterol. Motil. 21, 619-626.   DOI   ScienceOn
83 Tack, J., Vos, R., Janssens, J., Salter, J., Jauffret, S. and Vandeplassche, G. (2003b) Infl uence of tegaserod on proximal gastric tone and on the perception of gastric distension. Aliment. Pharmacol. Ther. 18, 1031-1037.   DOI   ScienceOn
84 Rhie, S. Y., Choi, C. H., Lee, H. W., Do, M. Y., Lee, S. H., Han, S. P, et al. (2007) The frequency of functional dyspepsia subtypes and its related factors for health check up subjects. Korean. J. Neurogastroenterol. Motil. 13, 31-37.
85 Talley, N. J., Camilleri, M., Burton, D., Thomforde, G., Koch, K., Rucker, M. J., Peterson, J., Zinsmeister, A. R. and Earnest, D. L. (2006) Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Aliment. Pharmacol. Ther. 24, 859-867.   DOI   ScienceOn
86 Ramsbottom, N. and Hunt, J. N. (1970) Studies of the effect of metoclopramide and apomorphine on gastric emptying and secretion in man. Gut 11, 989-993.   DOI   ScienceOn
87 Read, N. W., Abitbol, J. L., Bardhan, K. D., Whorwell, P. J. and Fraitag, B. (1997) Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 41, 664-668.   DOI
88 Romer, M., Painsipp, E., Schwetz, I. and Holzer, P. (2005) Facilitation of gastric compliance and cardiovascular reaction by repeated isobaric distension of the rat stomach. Neurogastroenterol. Motil. 17, 399-409.   DOI   ScienceOn
89 Rosch, W., Liebregts, T., Gundermann, K. J., Vinson, B. and Holtmann, G. (2006) Phytotherapy for functional dyspepsia: a review of the clinical evidence for the herbal preparation STW 5. Phytomedicine 13 Suppl 5, 114-121.   DOI   ScienceOn
90 Sarnelli, G., Sifrim, D., Janssens, J. and Tack, J. (2004) Influence of sildenafi l on gastric sensorimotor function in humans. Am. J. Physiol Gastrointest. Liver Physiol. 287, G988-992.   DOI   ScienceOn
91 Schemann, M., Michel, K., Zeller, F., Hohenester, B. and Ruhl, A. (2006) Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum. Phytomedicine 13 Suppl 5, 90-99.   DOI   ScienceOn
92 Stanghellini, V., De Ponti, F., De Giorgio, R., Barbara, G., Tosetti, C. and Corinaldesi, R. (2003) New developments in the treatment of functional dyspepsia. Drugs 63, 869-892.   DOI   ScienceOn
93 Sekino, Y., Yamada, E., Sakai, E., Ohkubo, H., Higurashi, T., Iida, H., Endo, H., Takahashi, H., Koide, T., Sakamoto, Y., Nonaka, T., Gotoh, E., Maeda, S., Nakajima, A. and Inamori, M. (2012) Influence of sumatriptan on gastric accommodation and on antral contraction in healthy subjects assessed by ultrasonography. Nuerogastroenterol. Motil. 24, 1083-e1564.   DOI   ScienceOn
94 Soji, Y., Kadokawa, T., Masuda, Y., Kawashima, K. and Nakamura, K. (1969) Effects of Corydalis alkaloid upon inhibition of gastric juice secretion and prevention of gastric ulcer in experimental animals. Nihon Yakurigaku Zasshi 65, 196-209.   DOI
95 Stanghellini, V., De Giorgio, R., Barbara, G., Cogliandro, R., Tosetti, C., De Ponti, F. and Corinaldesi, R. (2004) Delayed gastric emptying in functional dyspepsia. Curr. Treat. Options Gastroenterol. 7, 259-264.   DOI
96 Stevens, J. E., Russo, A., Maddox, A. F., Rayner, C. K., Phillips, L., Talley, N. J., Giguere, M., Horowitz, M. and Jones, K. L. (2008) Effect of itopride on gastric emptying in longstanding diabetes mellitus. Neurogastroenterol. Motil. 20, 456-463.   DOI   ScienceOn
97 Suzuki, H., Nishizawa, T. and Hibi, T. (2006) Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classifi cation. J. Gastroenterol. 41, 513-523.   DOI   ScienceOn
98 Tack, J. (2008) Prokinetics and fundic relaxants in upper functional GI disorders. Curr. Opin. Pharmacol. 8, 690-696.   DOI   ScienceOn
99 Mansi, C., Borro, P., Giacomini, M., Biagini, R., Mele, M. R., Pandolfo, N. and Savarino, V. (2000) Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol. Ther. 14, 561-569.   DOI   ScienceOn
100 Matsueda, K., Hongo, M., Tack, J., Saito, Y. and Kato, H. (2012) A placebo-controlled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 61, 821-828.   DOI
101 Mayer, E. A., Bradesi, S., Chang, L., Spiegel, B. M., Bueller, J. A. and Naliboff, B. D. (2008) Functional GI disorders: from animal models to drug development. Gut 57, 384-404.   DOI   ScienceOn
102 Mayer, E. A. and Gebhart, G. F. (1994) Basic and clinical aspects of visceral hyperalgesia. Gastroenterology 107, 271-293.
103 Mayrand, S., Tremblay, L. and Diamant, N. (1994) In vivo measurement of feline esophageal tone. Am. J. Physiol. 267, G914-921.
104 McCallum, R. W. and Cynshi, O. (2007a) Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis - a randomized, multicentre, placebo-controlled study. Aliment. Pharmacol. Ther. 26, 1121-1130.   DOI   ScienceOn
105 McCallum, R. W. and Cynshi, O. (2007b) Efficacy of mitemcinal, a motilin agonist, on gastrointestinal symptoms in patients with symptoms suggesting diabetic gastropathy: a randomized, multi-center, placebo-controlled trial. Aliment. Pharmacol. Ther. 26, 107-116.   DOI   ScienceOn
106 Miller, M. S., Galligan, J. J. and Burks, T. F. (1981) Accurate measurement of intestinal transit in the rat. J. Pharmacol. Methods 6, 211-217.   DOI   ScienceOn
107 Monroe, M. J., Hornby, P. J. and Partosoedarso, E. R. (2004) Central vagal stimulation evokes gastric volume changes in mice: a novel technique using a miniaturized barostat. Neurogastroenterol. Motil. 16, 5-11.   DOI   ScienceOn
108 Moro, E., Crema, F., De Ponti, F. and Frigo, G. (2004) Triptans and gastric accommodation: pharmacological and therapeutic aspects. Dig. Liver Dis. 36, 85-92.   DOI   ScienceOn
109 Nagahata, Y., Urakawa, T., Kuroda, H., Tomonaga, K., Idei, H., Kawakita, N., Yoshizumi, K. and Saitoh, Y. (1992) The effect of dopamine on rat gastric motility. Gastroenterol. Jpn. 27, 482-487.
110 Mundt, M. W., Hausken, T. and Samsom, M. (2002) Effect of intragastric barostat bag on proximal and distal gastric accommodation in response to liquid meal. Am. J. Physiol. Gastrointest. Liver Physiol. 283, G681-686.
111 Noh, Y. W., Jung, H. K., Kim, S. E. and Jung, S. A. (2010) Overlap of erosive and non-erosive refl ux diseases with functional gastrointestinal disorders according to Rome III criteria. J. Neurogastroenterol. Motil. 16, 148-156.   DOI   ScienceOn
112 Piessevaux, H., De Winter, B., Louis, E., Muls, V., De Looze, D., Pelckmans, P., Deltenre, M., Urbain, D. and Tack, J. (2009) Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol. Motil. 21, 378-388.   DOI   ScienceOn
113 Kessler, R. M., Ansari, M. S., de Paulis, T., Schmidt, D. E., Clanton, J. A., Smith, H. E., Manning, R. G., Gillespie, D. and Ebert, M. H. (1991) High affi nity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. J. Nucl. Med. 32, 1593-1600.
114 Kim, E. R., Min, B. H., Lee, S. O., Lee, T. H., Son, M. and Rhee, P. L. (2012) Effects of DA-9701, a novel prokinetic agent, on gastric accommodation in conscious dogs. J. Gastroenterol. Hepatol. 27, 766-772.   DOI   ScienceOn
115 Kim, Y. S., Lee, M. Y., Choi, E. s., Oh, J. T., Sohn, Y. W., Oh, Y. L., Ryu, H. S., Seo, G. S. and Choi, S. C. (2010) W1406 DA-9701, a new prokinetic agent, improves feeding inhibition by restraint stress in rats-comparative study with in vivo micro-animal. Gastroenterology 138, S-717.
116 Kuiken, S. D., Tytgat, G. N. and Boeckxstaens, G. E. (2005) Review article: drugs interfering with visceral sensitivity for the treatment of functional gastrointestinal disorders--the clinical evidence. Aliment. Pharmacol. Ther. 21, 633-651.   DOI   ScienceOn